Related Experiment Video
Updated: Jul 19, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Buphthalmos following systemic steroid treatment
1Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
Journal of Pediatric Ophthalmology and Strabismus
|October 7, 2006
Summary
Systemic corticosteroid treatment can cause juvenile glaucoma in infants, leading to increased intraocular pressure and buphthalmos. Discontinuing steroid use helped normalize eye pressure in this case.
Area of Science:
- Ophthalmology
- Pediatrics
- Endocrinology
Background:
- Corticosteroid-induced glaucoma is a known complication in adults.
- Its occurrence in pediatric populations, particularly infants, is less documented.
Observation:
- An infant receiving systemic steroid therapy developed juvenile glaucoma.
- The infant presented with buphthalmos, a sign of elevated intraocular pressure.
Findings:
- The infant's intraocular pressure normalized after cessation of corticosteroid treatment.
- This suggests a direct link between systemic steroid exposure and glaucoma development in infants.
Implications:
- Highlights the potential risk of systemic corticosteroids in pediatric glaucoma.
- Emphasizes the need for vigilant intraocular pressure monitoring in infants on steroid therapy.
- Informs clinical practice regarding steroid use in young children.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...